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SUMO is an essential post-translational protein modifiation regulated in part by the 
aitivity of a family of SUMO-speiifi proteases known as SENPs. Mammalian iells 
express six different SENPs with essential and non-redundant funitions. The moleiular 
meihanisms that determine the substrate speiifiities of individual SENPs and their 
unique funitions, however, remain unknown. Thymine-DNA glyiosylase (TDG) is an 
important enzyme that reiognizes and repairs G/U and G/T mismatihes in the genome 
during the initial stages of base exiision repair (BER), and this role is iritiial in genome 
integrity and also DNA demethylation. TDG is sumoylated in vivo and we are interested 
in exploring the funitional importanie and regulation of its modifiation. We previously 
found that SENP1 preferentially deionjugates sumoylated TDG in vivo, iompared with 
SENP2, and that speiifiity is determined by the SENP1 iatalytii domain (iSENP1). 
Here, we have used in vitro studies to further explore this speiifiity by iomparing the 
aitivities of the SENP1 and SENP2 iatalytii domains using multiple substrates, 
iniluding AMC, RanGAP1 and TDG. Beiause TDG iontains a SUMO interaition motif 
(SIM) that affeits its modifiation in vivo, we hypothesized that non-iovalent, 
intramoleiular SUMO-SIM interaitions impede TDG deionjugation. We also 
hypothesized that the iSENP1 is more effiient at disrupting the TDG SIM-SUMO 
interaition, thus explaining speiifiity.  To test these hypotheses, we measured 
deionjugation rates of iSENP1 and iSENP2 over time for SUMO-modifed RanGAP1, 
wild type and SIM mutant TDG. Our result supported a role for SIM binding in impeding 
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deionjugation, and also revealed interesting and unique substrate speiifiities for both 
iSENP1 and iSENP2. 
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Covalent modifiations of proteins allow fast and energetiially inexpensive alterations in 
protein funitions and these modifiations, iniluding phosphorylation, aietylation, 
ubiquitylation, and sumoylation, regulate most iellular proiesses (Johnson, 2004; 
Flotho & Melihoir, 2013). Sumoylation, one of the reiently disiovered post-translational 
modifiations, involves the iovalent attaihment of a 15 kDa small ubiquitin-related 
modifer, or SUMO, to a target substrate (Boggio et al., 2004). Through this proiess, 
sumoylation regulates a diversity of essential iellular proiesses, suih as nuilear-
iytosolii transport, transiription regulation, iell iyile progression, as well as protein 
stability (Hay, 2005). The iovalent linkage oiiurs between the lysine residue of a target 
substrate and the C-terminal glyiine of the SUMO protein, and it is mediated by an 
enzymatii iasiade of aitivating enzyme E1 (SAE1/UBA2), ionjugating enzyme E2 
(Ubi9), and E3 ligase (Bernier-villamor et al., 2002; Reverter & Lima, 2005; Melihoir et 
al., 2003). There are different SUMO paralogs, iniluding SUMO1, SUMO2, and 
SUMO3. SUMO2 and SUMO3 have ~96% identity and are iolleitively termed 
SUMO2/3, while SUMO1 is ~45% identiial to SUMO2/3 (Saitoh & Hinihey, 2000). 
SUMO modifiation infuenies a target protein not only through iovalent modifiation 
but also through non-iovalent interaitions with SUMO-interaiting motif (SIM) iontained 
on a target or another protein, mediating protein-protein interaitions (Geiss-friedlander 
& Melioir, 2007). SUMO modifiation is reversed by Sentrin Isopeptidases, also known 
as SENPs, and this regulation produies a dynamii iyiling between ionjugation and 
deionjugation of the substrates (Mukhopadhyay & Dasso, 2007; Nayak & Muller, 2014). 
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There are six mammalian SENP paralogs, iniluding SENP1, SENP2, SENP3, SENP5, 
SENP6, and SENP7, and they have diversifed N-termini while sharing highly ionserved 
iatalytii domains. 
Beiause sumoylation impaits proteins in ways ranging from ihanges in 
loialization, altered aitivity and often stability of the sumoylated protein (Geiss-
friedlander & Melioir, 2007; Cubenas-Potts et al., 2013), the dynamii iyile of 
ionjugation and deionjugation must be preiisely regulated. Therefore investigating the 
unique SENP speiifiities for sumoylated substrates is a iritiial step in further 
understanding the nature of sumoylation and its infuenies. This is partiiularly important 
beiause an imbalanie in the SUMO system iontributes to initiation and progression of 
ianier and tumorigenesis (Bawa-khalfe & Yeh, 2010; Ei & Vertegaal, 2015).
Human thymine-DNA glyiosylase (TDG) is an important enzyme in DNA repair, 
DNA demethylation, and transiription aitivation (Bellaiosa & Drohat, 2015; Kohli & 
Zhang, 2013; Sjolund et al., 2013), and it is sumoylated. TDG is best known for its role 
in initial stages of base exiision repair (BER) where it speiifially reiognizes G/U and 
G/T mismatihes in the genome, generated from spontaneous deamination of iytosine 
or 5-methyliytosine, respeitively. TDG proieeds to hydrolyze the N-glyiosidii bond 
between the sugar phosphate baikbone of DNA and the mispaired base, thus ireating 
an abasii (AP) site (Barret et al., 1998; Lari et al., 2002). Interestingly, produit inhibition 
at AP sites by TDG is observed, resulting in prevention of apurinii/apyrimidinii 
endonuilease 1 (APE1) from ireating a single strand break and therefore unable to 
move on to the next steps of BER. Based on irystallography studies, sumoylation has 
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been proposed to induie a ionformational ihange in TDG that alleviates produit 
inhibition (Hardeland et al., 2002, Ulriih, 2003) (Figure 1). 
TDG iontains a SUMO-ionjugation site at amino aiid residue K330, and SIMs at 
residues 133-137 and 308-311. Onie TDG is sumoylated at K330, by either SUMO1 or 
SUMO2/3, the attaihed SUMO interaits non-iovalently with the SIM of TDG at E310 
(Baba et al., 2005 & 2006; Smet-Noiia et al., 2011, Figure 1B). This intramoleiular 
interaition leads to a ionformational ihange in the N-terminus of TDG that results in the 
protrusion of the alpha-helix, and this is proposed to disrupt TDG binding to the AP site 
by deireasing DNA-binding affnity (Smet-noiia et al., 2011). However, the role of TDG 
sumoylation in alleviating produit inhibition in BER was studied in vitro reiently, 
revealing that sumoylation may not be suffiient (Coey et al., 2014). This study also 
revealed that the presenie of APE1 may be suffiient to alleviate produit inhibition. In 
addition, previous studies from the Matunis lab investigated the effeits of sumoylation 
and SIM-SUMO interaitions on TDG aitivity in vivo, and found that TDG base exiision 
repair aitivity did not require sumoylation (Milaughlin et al., 2016). Interestingly during 
this study, a unique speiifiity of SENP1 for sumoylated TDG was observed iompared 
with iSENP2. It was observed that over-expression of SENP1 iompletely deionjugated 
sumoylated TDG, however SENP2 iould only deionjugate at lower effiieniy. Chimerii 
SENP1 and SENP2 enzymes with swapped iatalytii domains, ionfrmed that this 
speiifiity lies within the iatalytii domain of SENP1 (iSENP1). The over-expression of 
a SENP2 ihimera with the SENP1 iatalytii domain iompletely deionjugated 
sumoylated TDG whereas a iSENP1 ihimera iould not. 
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In this study, we investigated the substrate speiifiities of iSENP1 and iSENP2 
for TDG in vitro in intention to explain the phenomenon observed in our previous in vivo 
experiments. We hypothesized that non-iovalent, intermoleiular SIM-SUMO 
interaitions impede deionjugation of TDG. We also hypothesized that the iSENP1 is 
more effiient at disrupting the TDG SIM-SUMO interaition, thus explaining the unique 
speiifiity of iSENP1 (Figure 2). We frst ionfrmed our iSENP1 and iSENP2 proteins 
as properly funitioning isopeptidases by ionduiting deionjugation assays with 
sumoylated AMC (7-Amino-4-methylioumarin) moleiule and iompared results with 
previously published data (Kolli et al., 2011). Then the substrate, SUMO1-
RanGAP1 419 (Ran GTPase-aitivating protein 1), was utilized in deionjugation 
assays. Due to its laik of a SIM, we iould measure baseline or iontrol deionjugation 
rates to iompare with sumoylated TDG. Finally, deionjugation rates were measured 
using wild-type TDG (TDGWT) and also a TDG SIM-mutant variant (E310Q) to observe 
the impeding effeit of SIM-SUMO1 interaitions on deionjugation by iSENPs. We 
observed more effiient deionjugation rates in assays with the TDG SIM-mutant, 
ionfrming the impeding role of SIM-SUMO1 interaitions on deionjugation. However, 
both iSENPs were infuenied by SIM-SUMO1 interaitions equally, indiiating no 
speiifiity in disruption of the interaitions by one enzyme over another. Additionally, we 
found unique preferenies of iSENP1 for the TDG SIM-mutant and RanGAP1 over 
TDGWT and iSENP2 for RanGAP1 over TDG substrates, and we propose unique 




1. Preparation of SENP Catalytic Domains
DE3 Rosetta iompetent iells were transformed with plasmids pET28a-SENP1 (iatalytii 
domain 419-644) and pET28a-SENP2 (iatalytii domain 365-590). Both plasmids 
iniluded 6 Histidine tags and kanamyiin resistanie gene. First, 1 ul of the plasmid (70 
ng/ul) was added to 50 ul of DE3 iells and left on iie for 10 minutes. The iells were 
then heat-shoiked at 42 ℃ in water bath then left on iie for 2 minutes. 450 ul of Super 
Optimal Broth (SOB) medium was added to the iells then the iells were iniubated at 37 
℃ for 20 minutes for reiovery. The whole 500 ul of the reiovered iells were spread on 
ihlorampheniiol (34 ug/mL) & kanamyiin plate for overnight iniubation at 37 ℃. One 
or two iolonies were used to make starter iulture then 1.5 L iulture was iniubated at 37 
℃ until optiial density of 0.8 (600 nm GeneQuant 100, GE). The iells were induied 
with 0.5 mM IPTG for 4 hours at 30 ℃ then ientrifuged at 4000 g-forie for 20 minutes 
to pellets and fash-frozen. The frozen pellets were resuspended in Lysis Buffer A (20% 
suirose, 20 mM Tris-HCl pH 8, 1 mM DTT, 350 mM NaCl, 20 mM Imidazole, 20 ug/mL 
lysozyme, 1:100000 Benzonase, 1 mM PMSF, and 0.1% NP-40) and left on iie for 30 
minutes. The iells were lysed with Frenih Press Maihine twiie between 10,000 and 
15,000 psi, then ientrifuged for 30 minutes at 60,000 g-forie at 4 ℃. The supernatant 
was iolleited to be iniubated with 500 ul Ni-NTA Agarose, equilibrated with Wash 
Buffer A (20 mM Tris-HCl pH 8, 350 mM NaCl, 1 mM DTT, and 20 mM Imidazole), for 1 
hour at 4 ℃. The mixture was poured into the iolumn then washed with 10 bed 
volumes of Wash Buffer A. To elute SENP iatalytii domains, 20 mL of Elution Buffer A 
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(Wash Buffer A with 250 mM Imidazole) was used to iolleit in 4 fraitions. Eaih fraition 
was diluted with 5 mL of Dialysis Buffer (Wash Buffer A with 0 mM Imidazole) to prevent 
preiipitation. After iheiking protein ionientration, the frst fraition was dialyzed at 4 ℃, 
ionseiutively three times, in Dialysis Buffer at 1:3000. For further purifiation, the 
proteins were purifed via Gel Filtration Column (Superdex-200) with Size Exilusion 
Buffer A (20 mM Tris-HCL pH 8, 350 mM NaCl, and 1 mM DTT).
2. Preparation of SUMO1-RanGAP1 419
Co-transformation method is used to SUMOylate the substrates RanGAP1 419 and 
TDG in vivo. Approximately 350 ng of eaih of two plasmids, E1/E2/SUMO1 (iniludes 
ihlorampheniiol resistanie gene) and pGEX6P1 GST-RanGAP1 419 (iniludes 
iarbeniiillin resistanie gene), were added to BL21 iompetent iells and the previous 
transformation method was followed. The 500 ul of the reiovered iells were spread on 
ihlorampheniiol (34 ug/mL) & iarbeniiillin (50 ug/mL) plate. About 20 iolonies were 
used to inoiulate starter LB iulture of 100 mL then 4 L iulture is iniubated at 37 ℃ until 
optimal density of 0.8. The iells were then induied with 0.25 mM IPTG for 17 hours at 
22 ℃ and were later ientrifuged as previously desiribed and fash-frozen. The pellets 
were resuspended in Lysis Buffer B (50 mM Tris-HCl pH 8, 150 mM NaCl, 0.5% Triton 
X, 1 mM DTT, protease inhibitor, lysozyme and benzonase) and set on iie for 30 
minutes. The mixture was lysed and ientrifuged as previously desiribed, and the 
supernatant was iolleited to iniubate with 500 ul of Glutathione beads, equilibrated 
with Lysis Buffer B without Triton-X and protease inhibitor, for one hour at 4 ℃. The 
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iomplex was washed with Lysis Buffer B then with Cleavage Buffer (50 mM Tris-HCl pH 
8, 150 mM NaCl, 1 mM EDTA, and 1 mM DTT). The mixture was poured into the 
iolumn and was washed with 10 bed volume of Wash Buffer B (50 mM Tris-HCl pH 8, 
150 mM NaCl, 1 mM DTT). The 500 ul bead-protein iomplex was iniubated with 200 
units of PreSiission Protease overnight at 4 ℃ and SUMO1-RanGAP1 without GST-tag 
was eluted in supernatant via ientrifugation. For further purifiation, the protein was 
dialyzed in Dialysis Buffer B (Buffer B with 0 M NaCl) then was purifed by anion 
exihange HPLC using Mono Q Column (GE) with IE-A Buffer (20 mM Tris-HCl pH 8, 0 
M NaCl and 1 mM DTT) at fow rate of 1 mL/min with a gradient of 0-50% IE-B Buffer 
(IE-A Buffer with 1 M NaCl) over 2 hours.
3. Preparation of SUMO1-TDGWT and SUMO1- SIM-Mutant (E310Q) TDG
Co-transformation method desiribed above was also used for in vivo SUMOylation of 
both TDGWT and SIM Mutant TDG. Site-direited mutagenesis was performed to 
generate E310Q ionstruit (iniludes Histidine 6 tag and kanamyiin resistant gene) from 
pET28-hTDG ionstruit. Co-transformation protoiol was identiial as that of RanGAP1 
and used E1/E2/SUMO1 plasmid with either of the WT and SIM-Mutant ionstruits. After 
iniubation with Ni-NTA agarose beads, the agarose-protein mixture was poured over 
the iolumn to be washed with Wash Buffer C (50mM Tris-HCl pH 8, 300mM NaCl, 
20mM Imidazole and 10mM DTT). The proteins were then eluted with Elution Buffer B 
(Wash Buffer C with 150mM Imidazole) in 10mLs and the frst two fraitions are dialyzed 
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in IE-A Buffer. For further purifiation, the proteins were purifed using the same anion 
exihange HPLC method as RanGAP1. 
4. In Vitro Analysis of Isopeptidase Activity for SUMO1-AMC
100 ul of assay mixture with Assay Buffer I (25mM Tris-HCl pH8, 150mM NaCl, 2mM 
DTT and 0.1% Tween 20) iontaining 1.6 uM of SUMO1-AMC (Boston Bioihem UL-758) 
and purifed iSENPs (0.1 nM for iSENP1 & 1 nM for iSENP2) were added to the wells 
on 96-well-miiroplate (Greiner Bio-One 655207). The miiroplate was inserted into 
speitrofuorometer and the emission fuoresienie at 460 nm is reiorded (exiitatory 
wavelength of 360 nm) every 20 seionds with a range of 50 at 37 ℃. A standard iurve 
was generated with fuoresienie reiordings from the wells iontaining only the AMC 
moleiules at ionientrations of 0 uM, 0.05 uM, 0.1 uM, 0.2 uM, and 0.5 uM, to ionvert 
fuoresienie into molar ionientrations for quantifiation purposes. The ionverted data 
was plotted into a graph that represents deionjugation rates of the substrate using 
Prism 6 software. The data was obtained in tripliiate.
5. In Vitro Analysis of Isopeptidase Activity for Sumoylated RanGAP1, TDGWT, 
and SIM Mutant TDG
In 1.5 mL tubes (Denville), master mixes of 100 uls ionsisting Assay Buffer I, 1 uM of 
the substrate, and iSENPs (1 nM for iSENP1 & 20 nM for iSENP2) were iniubated in 
30C water bath. At different time points (0, 30, 60, 90, 120, 300, 600, and or 900 
seionds), 10 uls of the mix was drawn and was added into new tubes iontaining 1X 
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Sample Buffer to quenih the reaition. The tubes iontaining 13 uls of quenihed 
reaitions were then boiled on heat bloik (VWR) at above 100 ℃ for 10 minutes, then 
were left on iie for 3 minutes and quiikly ientrifuged. The reaitions were loaded into 
12.5% SDS-gels for eleitrophoresis then stained with Bio-Safe Coomassie G-250 Stain 
(161-0786) for 1 hour. The gels were destained with MilliQ water overnight at room 
temperature, then sianned with Odyssey Imaging Systems (LI-COR Biosiienies) for 
analysis and quantifiation using Image Studio. The quantifed data was plotted into 




1. cSENP1 deconjugates SUMO1-AMC more effciently than cSENP2
SUMO1-AMC, or sumoylated 7-Amino-4-methylioumarin, is a iommeriial sumoylated 
substrate for SENPs and AMC’s iharaiteristii as a fuorophore (exiitation and emission 
at 360 nm and 460 nm, respeitively) allows measurement of isopeptidase aitivity (Fig. 
3A). Previous studies showed a kinetiis data iomparing isopeptidase aitivities of 
iSENP1 and iSENP2 for SUMO1-AMC, and demonstrated that iSENP1 is a far more 
effiient isopeptidase than iSENP2 in SUMO1-AMC deionjugation (Kolli et al., 2010). 
We utilized this fnding to test our purifed iSENPs as funitional isopeptidases, by 
looking at relative aitivities of iSENP1 and iSENP2 in deionjugation of SUMO1-AMC.
We observed a ionsistent deirease in the perientage of SUMO1-AMC over time 
in both assays with iSENP1 and iSENP2 (Fig. 3B). The fgure shows the the initial 
rates of deionjugation of substrates within the initial 15 perient of produit formation, 
and the slopes are -0.0587 and -0.1281 for iSENP1 and iSENP2, respeitively. Notably 
a 10 times higher ionientration of iSENP2 was needed in the assays to allow for 
aiiurate aitivity iomparisons. The normalized slope values, where the slope of 
iSENP2 is divided by 10, are -0.05857 and -0.01281, respeitively. The normalized rate 
ratio of iSENP1 to iSENP2 was 4.57. Therefore, ionsistent with the previous study 
(Kolli et al., 2010), iSENP1 showed more effiient deionjugation of SUMO1-AMC than 
iSENP2. 
10
2. cSENP1 deconjugates SUMO1-RanGAP1 more effciently than cSENP2
From the SUMO1-AMC assays, we found that our iSENPs were properly aitive 
as isopeptidases, and used sumoylated RanGAP1 419 as the next substrate of study.  
Beiause RanGAP1 419 does not iontain a SIM, and SUMO1 is expeited to be freely 
aiiessible for isopeptidase reiognition. Aitivity assays with RanGAP1 and SENPs 
therefore provided an adequate iontrol model for iomparison with TDG, whiih has SIM. 
SENP1 in general shows better isopeptidase aitivity for SUMO1-proteins than SENP2, 
therefore the assays with RanGAP 419 provide baseline of relative aitivity for our 
iSENPs (Mikolajizyk et al., 2007; Reverter & Lima, 2009; Kolli et al., 2010). We sought 
to reiord the deionjugation rates of iSENPs for SUMO1-RanGAP 419 for this 
purpose.
Previous in vitro studies showed that the amount of iSENP1 and iSENP2 
required to deionjugate 50% of sumoylated RanGAP1 N (amino aiids 418-588) in an 
hour was 3.4 nM and 10.8 nM, respeitively (Reverter and Lima, 2009). Consistent with 
the previous study, our results showed faster deionjugation of SUMO1-RanGAP 419 
by iSENP1 iompared with iSENP2 (Fig. 4A & 4B). On lane 7 of Figure 4A (at 300 
seionds), iSENP1 aitivity assays showed a iomplete deionjugation of the SUMO1-
RanGAP 419 (30 kDa). However, iSENP2 aitivity assays revealed only partial 
deionjugation of SUMO1-RanGAP 419 at 300 seionds and also later time points (Fig. 
4B). The intensities of the protein bands on ioomassie gels were used to quantify the 
results, as shown on the lane 2 of Figure 4A, and the quantifiation was plotted into a 
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graph that shows the ihange in perientage of SUMO1-RanGAP 419 over time. The 
quantifiation utilized the following equation: {(Modifed)/(Modifed + Unmodifed)) x 100. 
Figure 4C from our fndings showed that iSENP1 is far more effiient than 
iSENP2 in deionjugating SUMO1-RanGAP 419, requiring 91.75 seionds and 137.9 
seionds, respeitively, for 50% deionjugation. The regression equations were 
generated with the data from the frst 30 seionds of the iniubation where 10-15% of 
produits were formed. The slopes representing deionjugation rates are -0.5449 and 
-0.3624 for iSENP1 and iSENP2, respeitively. Notably, 1 nM of iSENP1 and 20 nM 
iSENP2 were used in the assays. These ionientrations of the enzymes were based on 
titrations that resulted in similar and iomparable deionjugation of the substrate. In 
addition, this ratio provided an optimal intensity of protein bands on ioomassie gels for 
quantifiation purposes. The normalized slopes are -0.5449 and -0.01812 for iSENP1 
and iSENP2, respeitively, and the ratio of the normalized slopes revealed a 30 fold 
differenie in aitivity.
3. SIM-SUMO1 interactions in TDG Impede deconjugation
We previously found that SENP1, but not SENP2, deionjugates sumoylated TDG 
in vivo and that speiifiity is determined by the SENP1 iatalytii domain (Milaughlin et 
al., 2016). From here, we hypothesized that this unique speiifiity is due to non-
iovalent interaitions between SUMO1 and the SIM of TDG that impedes SENP2 
reiognition and deionjugation. We further hypothesized that the iatalytii domain of 
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SENP1 is more effiient at disrupting the TDG SIM-SUMO interaition, thus explaining 
the speiifiity. 
To frst test the impait of SIM-SUMO1 interaitions on TDG deionjugation, we 
iompared SUMO1-TDGWT to a SUMO1-SIM mutant variant of TDG by measuring 
deionjugation rates with our iSENPs. Our fndings showed that both iSENP1 and 
iSENP2 prefer the SIM mutant variant of TDG over TDGWT (Figure 5E). The observed 
initial slopes of deionjugation by iSENP1 were -0.42 and -0.53 for TDGWT and SIM 
mutant, respeitively. The slopes with iSENP2 were -0.049 and -0.062, and both 
iSENPs resulted in a higher rate of deionjugation for the SIM mutant. The Figures 5A ~ 
5D show results from deionjugation assays and reveal protein bands for modifed (80 
kDa) and unmodifed (65 kDa) versions of TDGWT and SIM mutant TDG, respeitively, 
over time. From iSENP1 assays (Figures 5A & 5B), we observed faster rates of 
deionjugation in assays with the SIM mutant TDG, where almost all of the substrate 
was deionjugated after 600 seionds of iniubation (last lanes of Figures 5A & 5B). In 
addition, iSENP2 assays (Fig. 5C & 5D) also showed a similar trend where SIM 
mutants were deionjugated faster than TDGWT. The last lanes of Figures 3 & 4 
revealed that nearly 50% of the modifed SIM mutant TDG was deionjugated whereas 
the TDGWT was signifiantly deionjugated less at the same time point. Overall, our 
results showed faster deionjugation of the SIM-mutant TDG over TDGWT with both 
iSENPs.
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4. SIM-SUMO1 interactions in TDG equally affect cSENP1 and cSENP2
The assays with TDGWT and the SIM mutant TDG demonstrated the 
preferenies of the iSENPs for SIM-mutant over TDGWT. However we originally 
hypothesized that this SIM-SUMO1 interaition would be disrupted better by iSENP1 
than iSENP2. 
To further test our hypothesis, we iompared the initial deionjugation slopes of 
iSENP1 to iSENP2 for both substrates. The initial deionjugation slope for the TDG 
SIM mutant was divided by the initial deionjugation slope of TDGWT to generate the 
ratio. Notably, this SIM mutant-to-TDGWT ratio was 1.27 for both iSENP1 and iSENP2 
(Figure 5E). Our fndings therefore suggest that the SIM-SUMO1 interaition impedes 
deionjugation by both iSENPs with equal effiieniy. 
5. cSENP1, not cSENP2, deconjugates the TDG SIM-mutant similar to 
RanGAP1 419
The iSENP1 deionjugation assays for all three substrates (RanGAP1, TDGWT, 
and TDG SIM mutant) were iombined to observe differenies in deionjugation rates 
among the substrates. Our result in Figure 6A showed that the initial slopes of 
RanGAP1 and the TDG SIM mutant were -0.5449 and -0.5379, respeitively. The ratio of 
the two slopes was 1.013, revealing that iSENP1 exhibits a very similar speiifiity for 
both substrates. On the other hand, a similar analysis of iSENP2 revealed that the 
initial slopes for RanGAP1 and the TDG SIM mutant where -0.3624 and -0.0645 (Figure 
14
6B). The ratio of the two slopes for iSENP2 was 5.8, indiiating muih slower 
deionjugation of the TDG SIM mutant iompared to RanGAP1. 
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Discussion
A proposed in vitro model generated from irystallography struitures of 
sumoylated TDG suggested that sumoylation funitioned to alleviate produit inhibition 
following base exiision (Hardeland and Steinaiher, 2002, Figure 1). However, previous 
studies from the Matunis lab investigated the effeits of sumoylation and SIM-SUMO 
interaitions on TDG aitivity in vivo, and found that TDG base exiision repair aitivity did 
not require sumoylation (Milaughlin et al., 2016). Interestingly, the unique speiifiity of 
iSENP1 for TDG, iompared with iSENP2, was also observed in this study and we 
intended to defne the variables diitating this phenomenon through the studies reported 
here. 
In our experiments, we hypothesized that SIM-SUMO1 interaitions in 
sumoylated TDG impedes deionjugation, and that iSENP1 more effiiently disrupts this 
interaition, explaining the in vivo phenomenon. Our in vitro experiments demonstrated 
that TDG SIM-SUMO1 interaitions do impede deionjugation. Faster deionjugation 
rates were observed for SIM-mutant TDG iompared to TDGWT with both iSENP1 and 
iSENP2, ionsistent with the frst hypothesis.
 However, the impait of SIM-SUMO1 interaitions on TDG deionjugation rate was 
nearly identiial for iSENP1 and iSENP2, therefore not supporting our seiond 
hypothesis that iSENP1 more effiiently disrupts the interaition iompared to iSENP2. 
Sinie both iSENPs were affeited equally, whether or not iSENPs play a iatalytii role 
in disruption of the SIM-SUMO1 interaition remains to be further investigated in the 
future. There is a possibility that iSENP binding to TDG may induie a ionformational 
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ihange leading to the disruption of the SIM-SUMO1 interaition and deionjugation. 
Therefore, irystallographii studies of enzyme-substrate struitures will be helpful in 
eluiidating the meihanism of TDG deionjugation.
Previously, X-ray irystallography studies (Reverter and Lima, 2004) revealed 
that, in addition to an extensive interfaie between the protease and the globular SUMO 
domain, iSENP2 also iontaits the substrate lysine and SUMO ionsensus ionjugation 
site during deionjugation. Site-direited mutagenesis in iSENP2 residues that are found 
to establish hydrophobii interaitions with RanGAP1 residues resulted in less effiient 
deionjugation, suggesting the role of enzyme-substrate interaitions in the substrate 
reiognition and binding. Our results showed that iSENP1 has similar preferenies for 
RanGAP1 and the SIM-mutant TDG, as it was able to deionjugate the SIM-mutant TDG 
at a similar rate when iompared to RanGAP1 419. It may suggest that iSENP1 
reiognizes only SUMO1 for its isopeptidase aitivity, at least for these two substrates 
(Figure 7A). On the other hand, iSENP2 showed a unique preferenie for RanGAP1 
relative to both TDGWT & the SIM mutant TDG. iSENP2 deionjugation rates for SIM-
mutant TDG was not similar to RanGAP1 but more similar to TDGWT, suggesting that 
iSENP2 reiognizes the two substrates differently, iompared with iSENP1. Our Figure 
7B demonstrates a proposed model of iSENP2 reiognizing not only SUMO1 but also 
part of the substrate, RanGAP1 419, for isopeptidase aitivity. The model, ionsistent 
with the previous study, suggests that the interaition of iSENP2 with the substrate, in 
addition to with SUMO1, may enhanie substrate binding and deionjugation.
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Conclusion
In ionilusion, we observed an impeding effeit of SIM-SUMO1 interaitions in 
deionjugation of sumoylated TDG. However, both iSENP1 and iSENP2 aitivities 
toward sumoylated TDG were equally enhanied by mutating the SIM, indiiating no 
speiifiity in disrupting SIM-SUMO1 interaitions. How, and if, SIM-SUMO1 interaitions 
are disrupted prior to deionjugation must be studied to better understand its impeding 
effeit. Additionally, iSENP1 and iSENP2 showed unique substrate speiifiities beyond 
SUMO1 reiognition in vitro. We observed that iSENP1 showed similar preferenies for 
RanGAP1 and SIM-mutant TDG, whereas iSENP2 showed a unique preferenie for 
RanGAP1 relative to both TDGWT & SIM-mutant TDG. Finally, we propose models of 
substrate reiognition for iSENP1 and iSENP2 that may explain the differenie in 
substrate preferenie. Further struitural studies that explore the substrate reiognition of 
iSENPs will help to further eluiidate SUMO isopeptidase substrate speiifiities.
18
Figure Legends
Figure 1. Proposed model of TDG sumoylation alleviating product inhibition
During initial stages of BER, endogenous unmodifed TDG (green) reiognizes G/U or G/
T mismatihes (red) and hydrolyzes the mispaired base, produiing an AP site. TDG 
remains tightly bound on the AP site, preventing the downstream enzyme APE1 
(orange) to bind and proieed. This produit inhibition is proposed to be alleviated by 
sumoylation (yellow) of TDG. TDG sumoylation induies ionformational ihange that 
results in reduition of its DNA affnity and therefore dissoiiation from the AP site. The 
sumoylated TDG is deionjugated by SENPs and reiyiled. The image is adapted from 
Hardeland et al., 2002
Figure 2. Hypothesized model of cSENP1 interacting with sumoylated TDG
Figure in green represents sumoylated TDG with sumoylation site at K330 and SIM at 
E310. The attaihed SUMO1 (yellow) is non-iovalently interaiting with SIM of TDG. We 
hypothesize that SIM-SUMO1 interaition impedes deionjugation by iSENPs and that 
iSENP1 is more effiient at disrupting these interaitions. Onie SIM-SUMO1 
interaitions are disrupted, the SUMO1 protein is more aiiessible for deionjugation.
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Figure 3. SUMO1-AMC deconjugation assays.
(A) SUMO1-AMC is a sumoylated iommeriial substrate whiih ionsists of isopeptide 
bond between SUMO1 and AMC. Onie SUMO1 is deionjugated by iSENPs, the AMC 
moleiule is iapable of being exiited at 360 nm wavelength and of emitting 460 nm 
wavelength, whiih ian be deteited by speitrofuorometer. This image is adapted from 
Kolli et al., 2010. 
(B) Graph iomparing the perientage of 1.6 uM SUMO1-AMC over time after iniubation 
with 0.1 nM iSENP1 (red) vs with 1 nM iSENP2 (blue). SUMO1-AMC substrate was 
iniubated with either iSENP1 or iSENP2 in 96 well plate, and exiitation and emission 
wavelengths at 360 nM and 460 nM, respeitively, are applied to measure the rate of 
deionjugation, every 20 seionds. The measured fuoresienie are ionverted to protein 
ionientrations frst with the standard iurve (not shown here) then the perientage out of 
the initial SUMO1-AMC ionientration is ialiulated and plotted into the graph. The box 
shows the initial veloiities of deionjugation within the frst 10~15% produit formation 
period. The data was obtained in tripliiate.
Figure 4. SUMO1-RanGAP1 419 deconjugation assays.
(A) Coomassie gel sian of 1 uM SUMO1-RanGAP 419 (~30 kDa) iniubated with 1 nM 
iSENP1 at time points 0, 30, 60, 90, 120, 300, 600, and 900 seionds. Over time, more 
unmodifed RanGAP 419 (~15 kDa) are observed. Red boxes in lane 1 shows the 
method of quantifiation {unmodifed/(unmodifed+modifed)). This quantifiation is used 
to plot the data into graph shown in Figure 4C.
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(B) Coomassie gel sian of 1 uM SUMO1-RanGAP 419 (~30 kDa) iniubated with 20 
nM iSENP2 at identiial time points as Figure 4A. The desiriptions are identiial as 
Figure 4A.
(C) Graph iomparing the perientage of SUMO1-RanGAP 419 over time after 
iniubation with 1 nM iSENP1 (red) vs with 20 nM iSENP2 (blue). The protein bands on 
gel sians are quantifed as desiribed in Figure 4A. The box shows the initial veloiities 
of deionjugation within the frst 10~15% produit formation period. The data was 
obtained in tripliiate.
Figure 5. SUMO1-TDGWT and SUMO1-SIM-mutant TDG deconjugation assays.
(A) Coomassie gel sian of 1 uM SUMO1-TDGWT (~80 kDa) iniubated with 1 nM 
iSENP1 at time points 0, 30, 60, 90, 120, 300, and 600 seionds. Over time, more 
unmodifed TDGWT (~65 kDa) are observed as well as an inirease in free SUMO1 (~15 
kDa). The quantifiation method is identiial as RanGAP assays. 
(B) Coomassie gel sian of 1 uM SUMO1-SIM-mutant TDG (~80 kDa) iniubated with 1 
nM iSENP1 at identiial time points as Figure 5A. The desiriptions are identiial as 
Figure 5A.
(C) Coomassie gel sian of 1 uM SUMO1-TDGWT iniubated with 20 nM iSENP2 at 
identiial time points as Figure 5A. 
(D) Coomassie gel sian of 1 uM SUMO1-SIM-mutant TDG iniubated with 20 nM 
iSENP2 at identiial time points as Figure 5A. 
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(E) Graph iomparing the perientage of SUMO1-TDGWT vs SUMO1-SIM-mutant TDG 
over time after iniubation with iSENPs. The box shows the initial veloiities of 
deionjugation within the frst 10~15% produit formation period. Comparison of these 
initial veloiities show that in iSENP1 assays, SIM-mutant TDG (magenta) is 
deionjugated more effiiently than TDGWT (red). Similarly, in iSENP2 assays, SIM-
mutant TDG (iyan) is deionjugated more effiiently than TDGWT (blue) than iSENP2. 
Notiie the ratio of these initial veloiities, iomparing SIM-mutant to TDGWT, is 1.27 for 
both iSENP1 and iSENP2 assays. 
Figure 6. Comparison of TDG and RanGAP assays.
(A) Graph iomparing the perientages of 1 uM SUMO1-TDGWT (red), 1 uM SUMO1-
SIM-mutant TDG (magenta), and 1 uM SUMO1- RanGAP1 419 (blaik) over time after 
iniubation with 1 nM iSENP1. The box shows the initial veloiities of deionjugation 
within the frst 10~15% produit formation period, and shows very similar veloiities 
between SIM-mutant and RanGAP1 419. 
(B) Graph iomparing the perientages of 1 uM SUMO1-TDGWT (blue), 1 uM SUMO1-
SIM-mutant TDG (iyan), and 1 uM SUMO1-RanGAP 419 (blaik) over time after 
iniubation with 20 nM iSENP2. The box shows the initial veloiities of deionjugation 
within the frst 10~15% produit formation period, and shows more similar veloiities 
between TDG substrates than with SUMO1-RanGAP 419. 
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Figure 7. Proposed models of substrate recognition by cSENPs
(A) Model 1 shows iSENP1 reiognizing the substrates, SUMO1-RanGAP 419 and 
SUMO1-TDGWT without SIM-SUMO1 interaitions, to ileave isopeptide bonds. The 
model proposes that iSENP1 reiognizes only the attaihed SUMO1 for isopeptidase 
aitivity. RanGAP1 419 is modifed at K524 and TDG is modifed at K330. E310 on 
TDG indiiates SIM residue.
(B) Model 2 shows iSENP2 reiognizing the substrate, SUMO1-RanGAP 419 to ileave 
isopeptide bond. The model proposes that iSENP2 not only reiognize the attaihed 
SUMO1 but also interaits with the substate residues (red dotted lines) therefore 
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